Liver cancer research aims to unlock secrets of immunotherapy response
NCT ID NCT04145141
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study gathers blood, urine, stool, and tissue samples from 132 adults with primary liver cancer who are receiving or have received immunotherapy. Researchers will analyze these samples along with medical records to learn more about how liver cancer develops and responds to treatment. Participants are followed for life by phone or email, but no new treatments are given as part of this study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could help doctors design better, more personalized immunotherapies for liver cancer patients.
What could go wrong
This is an observational study, not a treatment trial. It collects data and samples but does not test a new therapy directly, so it may not lead to immediate changes in care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States